A-305 - A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma

التفاصيل البيبلوغرافية
العنوان:	A-305 - A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
المؤلفون:	Kaczmar, J., Papadopoulos, K., Ansstas, G., Birnbaum, A., Mehnert, J., Hamid, O., Hughes, B., Rabinowits, G., Wei, A., Yushak, M., Mani, J., Fang, F., Wang, J., Kroog, G., Salvati, M., Lowy, I., Fury, M., Lakhani, N.J.
المصدر:	In EJC Skin Cancer 2024 2 Supplement 1
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	27726118
DOI:	10.1016/j.ejcskn.2024.100213